Unique features of the okadaic acid activity class of tumor promoters

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 3-4, 1999, Pages 150-155

  Fujiki, Hirota ^a   Suganuma, Masami ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

IL 1; Inhibition of PP 1 and PP 2A; Okadaic acid pathway; TNF gene expression and release; TNF pathway; TPA pathway

Indexed keywords

OKADAIC ACID; TUMOR NECROSIS FACTOR ALPHA;

CANCER RISK; CELL STRAIN HL 60; CHEMICAL ANALYSIS; CYTOKINE PRODUCTION; GROWTH STIMULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SKIN CARCINOGENESIS; STOMACH CARCINOGENESIS; TUMOR GROWTH;

ANIMALS; CARCINOGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; OKADAIC ACID; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032932789     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050257     Document Type: Review

References (39)

1. Balmain A, Pragnell IB (1983) Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harveyras oncogene. Nature 303:72-74
2. Berenblum I, Shubik P (1947) A new quantitative approach to the study of the stages of chemical carcinogenesis in the mouse skin Br J Cancer 1:307-391
3. Boutwell RK (1977) The role of the induction of omithine decaboxylase in tumor promotion. In: Hiatt HH, Watson JD, Winsten DH (eds) Origin of Human Cancer, Cold Spring Harbor Laboratory, New York, pp 773-783
4. Christensen SB, Hergenhahn M, Roeser H, Hecker E (1992) Toxicodynamics of tumour promoters of mouse skin III. Specific binding of the tumor promoter thapsigargin as measured by the cold-acetone filter assay. J Cancer Res Clin Oncol 118:344-348
5. Fujiki H (1992) Is the inhibition of protein phosphatase 1 and 2A activities a general mechanism of tumor promotion in human cancer development? Mol Carcinog 5:91-94
6. Fujiki H, Suganuma M, Tahira T, Yoshioka A, Nakayasu M, Endo Y, Shudo K, Takayama S, Moore RE, Sugimura T (1984a) New classes of tumor promoters: Teleocidin, aplysiatoxin, and palytoxin, In: Fujiki H, Hecker E, Moore RE, Sugimura T, Weinstein IB (eds) Cellular interactions by environmental tumor promoters, Jpn Sci Soc Press Tokyo/VNU Science Press, Utrecht, pp 37-45
7. Fujiki H, Sugimura T (1987) New classes of tumor promoters: Teleocidin, aplysiatoxin, and palytoxin, Adv Cancer Res 49:223-264
8. Fujiki H, Suganuma M, Yoshizawa S, Kanazawa H, Sugimura T, Manam S, Kahn SM, Jiang W, Hoshina S, Weinstein IB (1989) Codon 61 mutations in the c-Harvey-ras gene in mouse skin tumors induced by 7,12-dimethylbenz(a)anthracene plus okadaic acid class tumor promoters. Mol Carcinog 2:184-187
9. Fujiki H, Suganuma M (1993) Tumor promotion by inhibitors of protein phospatases 1 and 2A: The okadaic acid class of compounds. Adv Cancer Res 61:143-194
10. Fujiki H, Sueoka E, Komori A, Suganuma M (1997) Tumor promotion and TNF-α gene expression by the okadaic acid class tumor promoters. Environ Carcino & Ecotox Revs C15(1):1-40
11. Fujiki H, Tanaka Y, Miyake R, Kikkawa U, Nishizuka Y, Sugimura T (1984b) Activation of calcium-activated, phospholipid-dependent protein kinase (protein kinase C) by new classes of tumor promoters: teleocidin and debromoaplysiatoxin. Biochem Biophys Res Commun 120:339-343
12. Guy GR, Cao X, Chua SP, Tan YH (1992) Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1. J Biol Chem 267:1846-1852
13. Hakii H, Fujiki H, Suganuma M, Nakayasu M, Tahira T, Sugimura T, Scheuer PJ, Christensen SB (1986) Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanoylphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis. J Cancer Res Clin Oncol 111:177-181
14. Hecker E (1967) Phorbol Esters from Croton Oil - chemical Nature and biological Activities. Naturwissenschaften 54:282-284
15. Hecker E (1968) Cocarcinogenic principles from the seed oil of Croton tiglium and from other Euphorbiaceae. Cancer Res 38:2338-2349
16. Hecker E (1985) Cell membrance associated protein kinase C as receptor of diterpene ester cocarcinogens of the tumor promoter type and the phenotypic expression of tumors. Arzneimittel-Fosch. (Drug Research) 35:1890-1903
17. Hecker E, Bresch H, von Szczepanski C (1964) Cocarcinogen Al -the first pure, highly active constituent of croton oil, Angew Chem Intern Ed Engl 3:227
18. Hescheler J, Mieskes G, Ruegg JC, Takai A, Trautwein W (1988) Effects of a protein phosphatase inhibitor, okadaic acid, on membrane currents of isolated guinea-pig cardiac myocytes. Pflugers Arch 412:248-252
19. Kim SJ, Lafyatis R, Kim KY, Angel P, Fujiki H, Karin M, Spom MB, Roberts AB (1990) Regulation of collagenase gene expression by okadaic acid, an inhibitor of protein phosphatases. Cell Regulation 1:269-278
20. Kazanietz MG, Barchi JJ, Omichinski JG & Blumberg P (1995) Low affinity binding of phorbol esters to protein kinase C and its recombinant cysteine-rich region in the absence of phospholipids. J Biol Chem 270:14679-14684
21. Kloz U, Hergenhahn M, Fellhauer M, Hecker E (1989) Induction of Epstein-Barr virus early antigens by tumor promoters of the diterpene ester type in Raji cells and specific (receptor) binding as compared to irritant and promoting activities. J Cancer Res Clin Oncol 115:148-156
22. Komori A, Yatsunami J, Suganuma M, Okabe S, Abe S, Sakai A, Sasaki K, Fujiki H (1993) Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res 53:1982-1985
23. Krauter G, von der Lieth CW, Schmidt R, Hecker E (1996) Structure/activity relationships of polyfunctional diterpenes of the tigliane type, VIII A pharmacophore model for protein kinase C activators based on structure/activity studies and molecular modeling of the tumor promoters 12-O-tetradecanoylphorbol-13-acetate and 3-O-tetradecanoylingenol. Eur J Biochem 242:417-427
24. Li Y-M, Casida JE (1992) Cantharidin-binding protein: Identification as protein phosphatase 2A. Proc Natl Acad Sci USA 89:11867-11870
25. Nishiwaki-Matsushima R, Ohta T, Nishiwaki S, Suganuma M, Kohyama K, Ishikawa T, Carmichael WW, Fujiki H (1992) Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR. J Cancer Res Clin Oncol 118:420-424
26. Nishizuka Y (1984) The role of protein kinase C in cell surface transduction and tumor promotion. Nature 308:693-698
27. Ohta T, Sueoka E, Iida N, Komori A, Suganuma M, Nishiwaki R, Tatematsu M, Kim SJ, Carmichael WW, Fujiki H (1994) Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver. Cancer Res 54:6402-6406
28. Okabe S, Sueoka N, Komori A, Suganuma M, Endo Y, Shudo K, Fujiki H (1998) Twist form of teleocidin derivatives is active in in vivo tumor promotion by (-)-benzolactam-V8-310. Biol Pharm Bull 21:465-468
29. Suganuma M, Fujiki H, Suguri H, Yoshizawa S, Hirota M, Nakayasu M, Ojika M, Wakamatsu K, Yamada K, Sugimura T (1988) Okadaic acid: An additional non-phorbol-12-tetra-decanoate-13-acetate-type tumor promoter. Proc Natl Acad Sci USA 85:1768-1771
30. Suganuma M, Suttajit M, Suguri H, Ojika M, Yamada K, Fujiki H (1989) Specific binding of okadaic acid, a new tumor promoter in mouse skin. FEBS Lett 250:615-618
31. Suganuma M, Fujiki H, Furuya-Suguri H, Yoshizawa S, Yasumoto S, Kato Y, Fusetani N, Sugimura T (1990) Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin. Cancer Res 50:3521-3525
32. Suganuma M, Fujiki H, Okabe S, Nishiwaki S, Brautigan D, Ingebritsen TS, Rosner MR (1992a) Structurally different members of the okadaic acid class selectively inhibit protein serine/threonine but not tyrosine phosphatase activity. Toxicon 30:873-878
33. Suganuma M, Tatematsu M, Yatsunami J, Yoshizawa S, Okabe S, Uemura D, Fujiki H (1992b) An alternative theory of tissue specificity by tumor promotion of okadaic acid in glandular stomach of SD rats. Carcinogenesis 13:1841-1845
34. Suganuma M, Yatsunami J, Yoshizawa S, Okabe S, Fujiki H (1993) Absence of synergistic effects on tumor promotion in CD-1 mouse skin by simultaneous applications of two different types of tumor promoters, okadaic acid and teleocidin. Cancer Res 53:1012-1016
35. Suganuma M, Okabe S, Sueoka E, Nishiwaki R, Komori A, Uda N, Isono K, Fujiki H (1995) Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach. J Cancer Res Clin Oncol 121:621-627
36. Thevenin C, Kim SJ, Rieckamann P, Fujiki H, Norcross MA, Spom MB, Fauci AS, Kehrl JH (1990) Induction of nuclear factor-κB and the human immunodeficiency virus long terminal repeat by okadaic acid, a specific inhibitor of phosphatases 1 and 2A. New Biol 2:793-800
37. Yoshizawa S, Fujiki H, Suguri H, Suganuma M, Nakayasu M, Matsushima R, Sugimura T (1990) Tumor-promoting activity of staurosporine, a protein kinase inhibitor on mouse skin. Cancer Res 50:4974-4978
38. Van Duuren BL (1969) Tumor promoting agents in Two-stage Carcinogenesis. Prog Exptl Tumor Res 11:31-68
39. Van Duuren BL, Orris L (1965) The tumor-enhancing principles of Croton tiglium L. Cancer Res 25:1871-1875